Latest News & Features
Big Pharma
The German Federal Patent Court has set aside a decision by the German Patent and Trade Mark Office to reject a supplementary protection certificatesupplementary protection certificate that GSK Biologicals had applied for, in a decision of “fundamental importance”. 8 March 2018
Europe
The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology. 7 March 2018
Americas
AstraZeneca’s research development arm MedImmune has revealed plans to spin out six molecules into an independent biotech company. 6 March 2018
Americas
Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox. 6 March 2018
Big Pharma
The UK’s Prime Minister has revealed that the UK would be willing to remain part of the European Medicines Agency after Brexit. 5 March 2018
Americas
Swiss-based pharmaceutical company Helsinn Healthcare has filed a petition for writ of certiorari with the US Supreme Court. 5 March 2018
Americas
The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity. 2 March 2018
Europe
The EU General Court has dismissed a request to revoke a syringe trademark on the grounds of non-use, partially affirming the initial decision of the Cancellation Division. 1 March 2018
Americas
DowDuPont, a specialist in agriculture, materials science and speciality products, has revealed the names of three independent companies that it intends on creating. 1 March 2018
Americas
Late last week, the Patent Trial and Appeal Board rejected a Native American tribe’s attempt to dismiss inter partes reviews based on the tribe’s sovereign immunity claims. 1 March 2018